Catalyst Historical Valuation

CPRX Stock  USD 22.11  0.37  1.70%   
Some fundamental drivers such as market cap or Catalyst Pharmaceuticals enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Catalyst Pharmaceuticals valuation indicators such as Working Capital of 0.0 or Enterprise Value of 1.7 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Catalyst Pharmaceuticals's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalyst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

About Catalyst Valuation Data Analysis

Valuation is the financial process of determining what Catalyst Pharmaceuticals is worth. Catalyst Pharmaceuticals valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Catalyst Pharmaceuticals valuation ratios help investors to determine whether Catalyst Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Catalyst with respect to the benefits of owning Catalyst Pharmaceuticals security.

Catalyst Pharmaceuticals Valuation Data Chart

Market Cap is likely to rise to about 1.9 B in 2024. Enterprise Value is likely to rise to about 1.7 B in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Catalyst Pharmaceuticals theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Catalyst Pharmaceuticals debt, but would also pocket its cash. Enterprise Value is more accurate representation of Catalyst Pharmaceuticals value than its market capitalization because it takes into account all of Catalyst Pharmaceuticals existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.